Titlebook: Cardio-Renal Clinical Challenges; David Goldsmith,Adrian Covic,Jonas Spaak Book 2015 Springer International Publishing Switzerland 2015 An

Leisureliness

Vitamin D and Its Effects on the Heartmmetric left ventricular hypertrophy, chronic kidney disease Stage 3B presents in follow up of his multiple cardiovascular issues. He has a normal serum calcium level and his parathyroid hormone is within target range. Would this patient benefit of vitamin D treatment and if so, which form and dose

斗志

兵團

Pulmonary Hypertension in CKD: A New Problem Childt diseases and several CKD-specific risk factors, including the presence of artero-venous fistula, fluid overload, sleep breathing disorders and the exposure to dialysis membranes, can be implicated at various level in the genesis of PH in the CKD population. PH in CKD is a potentially reversible pr

indubitable

How to Use Inhibitors of the Renin-Angiotensin-Aldosterone System in Patients with CKD and Heart Failining kidney function [1]. In the Atherosclerosis Risk in Communities (ARIC) Study [2], a large, population-based study of U.S. adults, the incidence of HF was three-fold higher in individuals with an estimated glomerular filtration rate (GFR) <60 mL/min/1.73 m., compared with the reference group w

極大的痛苦

Erectile and Sex Hormone Dysfunction and Cardiovascular Consequences in CKDempts have been made to implement ED in well-known CV risk scoring systems. ED has been described as just one manifestation of the generalized atherosclerosis syndrome, similar to angina pectoris. Interestingly ED appears a few years before other clinical manifestations of cardiac disease, particula

Flu表流動

笨拙的我

Macronutrients

https://doi.org/10.1007/978-3-319-09162-4Anticoagulation; Arrhythmia; Arterial Stiffening; CKD; CVD; Calcification; Cardio-renal; Cardiovascular Dis

Chivalrous

978-3-319-34870-4Springer International Publishing Switzerland 2015

有角